Clinical Trials Logo

Clinical Trial Summary

The primary objective of this study is to identify and describe patient behaviors and clinical outcomes among patients who have tested positive for mild to moderate COVID-19.


Clinical Trial Description

This virtual observational cohort study will describe patient behaviors and clinical outcomes of subjects who tested positive for COVID-19. Among those with positive tests, predictors of time to recovery, post-COVID function and outcomes will be identified. Individuals who test negative and positive for SARS-CoV-2 will be enrolled in the study. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05042232
Study type Observational
Source Everly Health
Contact
Status Completed
Phase
Start date April 19, 2021
Completion date June 14, 2022

See also
  Status Clinical Trial Phase
Recruiting NCT05063214 - Muscle Evaluation of Patients Infected by the Coronavirus
Not yet recruiting NCT05013034 - Exploratory Regimen of Basiliximab for Treatment of Pulmonary Cytokine Storm in SARS-CoV-2 Hospitalized Adult Patients Phase 2
Completed NCT04998253 - Effects in Oxygenation and Hypoxic Pulmonary Vasoconstriction in ARDS Secondary to SARS-CoV2 Early Phase 1
Active, not recruiting NCT05167227 - Does a Technology Enabled Multi-disciplinary Team-based Care Model for the Management of Long COVID and Other Fatiguing Illnesses Improve Clinical Care of Patients and Represent a Sustainable Approach Within a Federally Qualified Health Center? N/A
Withdrawn NCT05393999 - SABRE: A Single-arm Prospective Study Measuring Safety and Tolerability of SARS-CoV-2 Neutralising Antibodies in High-risk Populations Phase 2
Completed NCT05142553 - Immunogenicity and Safety of a Booster Vaccination With a Recombinant Protein RBD Candidate Vaccine Against SARS-CoV-2 in Healthy Adults Volunteers Fully Vaccinated Followed by an Extension Period to Study a Fourth Dose Administration. Phase 2
Recruiting NCT04929691 - The CircumVent Project: A CPAP/O2 Helmet Solution for Non-Invasive Ventilation Among Patients With COVID-19 N/A
Completed NCT05142514 - Safety and Immunogenicity of Recombinant Protein RBD Fusion Dimer Vaccine Against the Virus That Cause COVID-19, Known as Severe Acute Respiratoy Syndrome Coronavirus 2 (SARS-CoV-2) Phase 2
Withdrawn NCT04894682 - Safety and Long-term Effects of COVID-19 Vaccines in Patients With Pulmonary Tumor
Completed NCT04845048 - Active Pharmacovigilance Study of Adsorbed COVID-19 (Inactivated) Vaccine
Completed NCT05638178 - The Corona Study of Middle Norway
Not yet recruiting NCT05248373 - Safety, Tolerability and Immunogenicity of Gam-COVID-Vac Vaccine in a Nasal Spray Phase 1/Phase 2
Not yet recruiting NCT05074121 - NAC for Attenuation of COVID-19 Symptomatology Phase 2
Completed NCT05305573 - Assessing the Immunogenicity and Safety of a HIPRA's Candidate Booster Vaccination in Adults Fully Vaccinated With Adenovirus Vaccine Against COVID-19. Phase 2
Completed NCT05042193 - A Prospective Virtual Study to Evaluate the Longevity of IgG Antibodies in Individuals Exposed to COVID-19
Completed NCT04896866 - Efficacy and Safety of Antimicrobial Stewardship Intervention in Hospitalized COVID-19 Patients (COVASP) N/A
Completed NCT04371471 - Pandemic Triage Score in Patients With Known or Suspected Severe Acute Respiratory Syndrome (SARS) CoronaVirus (CoV) 2 Infection
Completed NCT05008562 - How COVID-19 Effects to Muscle Mass Change ın ICU?
Completed NCT04954157 - Studies to Determine Whether Oxygen Sensing is Impaired in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infected Patients N/A
Recruiting NCT05133596 - Study of the Evolution of Olfactory Disorders in Patients With Persistent Loss of Smell Following COVID-19 N/A